In one hand, a slender young woman holds up a bottle of clear liquid. The words “Skinny” and “GLP-1” — a new class of weight loss drugs — are visible on the label. In the other hand, she raises up a pipette filled with the liquid, as if to drop it in her open mouth. “Lose up to 15% of your body weight,” reads the caption on the Instagram post.

The death of a nurse from North Lanarkshire has been linked to the use of a weight-loss drug recently approved for use on the NHS. Susan McGowan, 58, took two low-dose injections of tirzepatide, known under the brand name Mounjaro, over the course of about two weeks before her death on 4 September.

A new clinical trial found that weight-loss drug Wegovy shows promise for lowering the risk of heart attack and stroke among people with heart disease and obesity.

Ozempic has been talk of the town for a while now, not only for helping people with diabetes, but also for working as a weight loss drug. Global celebrities like Amy Schumer, Sharon Osbourne, and Kathy Bates have admitted to using this medication to drop extra pounds.